tirzepatide meal timing weight loss studies Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain efficacy Tirzepatide leads to weight reduction

Clinical trials (SURPASS program) have demonstrated that tirzepatide produces substantial reductions in hemoglobin A1c (HbA1c), with decreases ranging from 1.9% to 2.6% depending on the dose used

The science is moving fast, and the tools you need to optimize your biology are available right now

Use adequate contraception while taking this medication

Based on UK Dietary Reference Values (DRVs) and estimates from the Scientific Advisory Committee on Nutrition (SACN), breastfeeding women require on average approximately 400500 additional calories per day above their pre-pregnancy baseline during the early months of exclusive breastfeeding